{
  "id": 5194,
  "text": "Lancet Oncol 2005;6:271-278.Available at: http://www.ncbi.nlm.nih.gov/pubmed/15863374.13.Ault KA.Effect of prophylactic human papillomavirus L1 virus-likeparticle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Lancet Oncol 2005;6:271-278.Available at: http://www.ncbi.nlm.nih.gov/pubmed/15863374.13.Ault KA.Effect of prophylactic human papillomavirus L1 virus-likeparticle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "接种预防性人乳头瘤病毒（HPV）L1病毒样颗粒疫苗显著降低了宫颈上皮内瘤病2级、3级以及原位腺癌的风险。这些疫苗通过预防感染与高危HPV类型相关的病变，从而有效降低了宫颈癌前病变的发生率。综联合随机临床试验的分析表明，疫苗在预防这些高风险病变方面展现出显著的保护效果。因此，疫苗接种是关键的公共卫生措施之一，有助于减少与HPV相关的宫颈癌及其病变的发生。",
  "query": "接种预防性人乳头瘤病毒L1病毒样颗粒疫苗如何影响宫颈上皮内瘤病2级、3级以及原位腺癌的风险？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 接种预防性人乳头瘤病毒L1病毒样颗粒疫苗如何影响宫颈上皮内瘤病2级、3级以及原位腺癌的风险？\n\n<reference text>: Lancet Oncol 2005;6:271-278.Available at: http://www.ncbi.nlm.nih.gov/pubmed/15863374.13.Ault KA.Effect of prophylactic human papillomavirus L1 virus-likeparticle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "接种预防性人乳头瘤病毒（HPV）L1病毒样颗粒疫苗显著降低了宫颈上皮内瘤病2级、3级以及原位腺癌的风险。这些疫苗通过预防感染与高危HPV类型相关的病变，从而有效降低了宫颈癌前病变的发生率。综联合随机临床试验的分析表明，疫苗在预防这些高风险病变方面展现出显著的保护效果。因此，疫苗接种是关键的公共卫生措施之一，有助于减少与HPV相关的宫颈癌及其病变的发生。"
}